ŷ��Ʒ Feature Channel: Infectious Diseases

Covid-19 Hits Older Adults Hardest; Which Ones Want the Updated Vaccine

Michigan Medicine - University of Michigan — Mon, 23 Sep 2024 06:00:00 EST

A poll of people over the age of 50 shows that just under half are likely to get the updated COVID-19 vaccine, though those in the highest-risk age groups are more likely.

What To Know About Vaccines As We Enter the Winter Season

George Washington University — Thu, 19 Sep 2024 10:05:43 EST

Dengue Fever Lands in LA: How Global Warming Is Affecting Health

Cedars-Sinai — Tue, 17 Sep 2024 17:05:21 EST

Amid southern california's recent record-breaking heat wave and fast-moving wildfires, public health officials reported the third locally acquired case of dengue fever in the los angeles area. Although the events seem unrelated, they actually are connected--and for troubling reasons.

LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives

La Jolla Institute for Immunology — Tue, 17 Sep 2024 17:05:16 EST

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA--At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential

Wistar Institute — Tue, 17 Sep 2024 14:05:21 EST

Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.

Large-Scale Study Will Seek to Unearth Causes of Persistent Symptoms of Lyme Disease

Tufts University — Tue, 17 Sep 2024 10:05:40 EST

Tufts University researchers have received a $20.7 million grant to lead the largest NIH-funded prospective study of patients with chronic Lyme disease to date, following patients from their earliest diagnosis to better identify why some people go on to develop debilitating symptoms later on.

T cells may offer some protection in an H5N1 'spillover' scenario

La Jolla Institute for Immunology — Mon, 16 Sep 2024 13:05:34 EST

The LJI team uncovered important similarities between H5N1 and these common viruses, which allowed them to predict that many people already have "cross-reactive" T cells that are ready to target H5N1--should it ever mutate to cause widespread disease in humans.

WashU Medicine Leads Two Major Pandemic Preparedness Research Projects

Washington University in St. Louis — Mon, 16 Sep 2024 10:05:37 EST

WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years.

Your Best Bet for Avoiding Illness from Flu and COVID-19? Getting Vaccinated.

Rutgers University-New Brunswick — Fri, 13 Sep 2024 09:05:32 EST

An infectious disease expert at Rutgers Health explains the importance of getting crucial shots this fall

Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control

Beth Israel Lahey Health — Thu, 12 Sep 2024 09:05:26 EST

In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.

New national survey shows hesitancy about vaccines this fall

Ohio State University Wexner Medical Center — Thu, 12 Sep 2024 00:05:00 EST

With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this year's flu shot rolls out and following the FDA's approval of an updated round of COVID-19 vaccines.

LJI Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network

La Jolla Institute for Immunology — Wed, 11 Sep 2024 12:05:47 EST

La Jolla Institute for Immunology (LJI) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).

A Cleveland Clinic-Led Study Published in Clinical Infectious Diseases Examined How the 2019 ATS/IDSA Guidelines Would Have Applied to Adult Patients with Community-Acquired Pneumonia.

Cleveland Clinic — Wed, 11 Sep 2024 11:05:19 EST

1 in 5 COVID deaths potentially attributable to hospital caseload strain

American College of Physicians (ACP) — Mon, 09 Sep 2024 17:00:00 EST

A nationwide retrospective cohort study evaluated the effect of COVID-19 caseload stress on the probability of in-hospital mortality or discharge to hospice. The data revealed a detrimental relationship between COVID-19 caseload and survival across all hospital types, far beyond the pandemic's learning curve.

COVID-19 Lockdowns Prematurely Aged Teenage Brains, UW Study Shows

University of Washington — Mon, 09 Sep 2024 16:05:52 EST

New research from the University of Washington found lockdowns during the COVID-19 pandemic resulted in unusually accelerated brain maturation in adolescents. This maturation was more pronounced in girls. When measured in terms of the number of years of accelerated brain development, the mean acceleration was 4.2 years in females and 1.4 years in males.

A vision for effective community-based ecosystems of Latine health by 2050

University of California, Irvine — Mon, 09 Sep 2024 12:05:47 EST

With Latine individuals now representing the largest racially minoritized group in the U.S., promotores, or community health workers (CHW), are crucial in addressing systemic health inequities that have historically affected Latine communities, especially working-class Latines.

While Vaccines Target the Changing Parts of Coronavirus, Researchers Suggest It's the Unchanging Parts We Also Need to Pay Attention to

Corewell Health — Mon, 09 Sep 2024 11:05:33 EST

For the past three years, Corewell Health researchers have been studying the genetic code of the virus that causes COVID-19 to better understand how it is changing and how to avoid another pandemic. Much of the world's focus has been on the development of vaccines to prevent the spread of the virus; however, vaccines primarily target the portion of the virus that constantly changes, requiring vaccines to be regularly updated.

Chula Professor Receives United Nations Public Service Awards (UNPSA 2024) for His Innovation "Academic Insight into Action for Pandemic Response"

Chulalongkorn University — Mon, 09 Sep 2024 08:55:52 EST

Dr. Jatuwat Sangsanont from the Department of Environmental Science at the Faculty of Science, Chulalongkorn University, has been awarded the United Nations Public Service Awards (UNPSA 2024) in the 'Innovation in Public Institutions' category.

Rutgers School of Public Health Dean Receives Helen Rodriguez-Trias Social Justice Award

Rutgers University-New Brunswick — Sun, 08 Sep 2024 07:05:44 EST

Perry N. Halkitis, dean of the Rutgers School of Public Health, has received the 2024 Helen Rodriguez-Trias Social Justice Award from the American Public Health Association for his advocacy work and research aimed at improving the health of LGBTQ+ people and populations.

Rutgers Inventors Receive Edison Patent Awards in Industrial Processes, Medical Diagnostics Categories

Rutgers University's Office for Research — Fri, 06 Sep 2024 16:05:29 EST

A catalyst that converts waste CO₂ to chemical products. A monoclonal antibody that could revolutionize the detection of tuberculosis. Both innovations were developed at rutgers, The State University of New Jersey, and both have received 2024 Edison Patent Awards.

ŷ����Ʒ Feature Channel: Infectious Diseases